{"id":"https://openalex.org/W46975204","doi":null,"title":"Anticancer drug delivery with nanoparticles.","display_name":"Anticancer drug delivery with nanoparticles.","publication_year":2006,"publication_date":"2006-11-01","ids":{"openalex":"https://openalex.org/W46975204","mag":"46975204","pmid":"https://pubmed.ncbi.nlm.nih.gov/17203748"},"language":"en","primary_location":{"id":"pmid:17203748","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17203748","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"In vivo (Athens, Greece)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056757501","display_name":"Matteo Conti","orcid":"https://orcid.org/0000-0002-1579-9674","observed_orcids":["https://orcid.org/0000-0002-1579-9674"]},"institutions":[{"id":"https://openalex.org/I4210092828","display_name":"Ospedale \"Santa Maria delle Croci\" di Ravenna","ror":"https://ror.org/00g6kte47","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210092828","https://openalex.org/I4210107542"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Matteo Conti","raw_affiliation_strings":["Laboratorio di Tossicologia e Farmacologia Clinica, Ospedale S. Maria delle Croci, Ravenna, Italy. ra.hotossicologia@ausl.ra.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio di Tossicologia e Farmacologia Clinica, Ospedale S. Maria delle Croci, Ravenna, Italy. ra.hotossicologia@ausl.ra.it","institution_ids":["https://openalex.org/I4210092828"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021866334","display_name":"Valeria Tazzari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141399","display_name":"Istituto Oncologico Romagnolo","ror":"https://ror.org/04mrg3p52","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210141399"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Valeria Tazzari","raw_affiliation_strings":["Istituto Oncologico Romagnolo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Oncologico Romagnolo","institution_ids":["https://openalex.org/I4210141399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083436848","display_name":"Cesare Baccini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141399","display_name":"Istituto Oncologico Romagnolo","ror":"https://ror.org/04mrg3p52","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210141399"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cesare Baccini","raw_affiliation_strings":["Istituto Oncologico Romagnolo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Oncologico Romagnolo","institution_ids":["https://openalex.org/I4210141399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064902593","display_name":"Gianni Pertici","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gianni Pertici","raw_affiliation_strings":["University of Pisa,#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pisa,#TAB#","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059022743","display_name":"Lorenzo Pio Serino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lorenzo Pio Serino","raw_affiliation_strings":["University of Pisa,#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pisa,#TAB#","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071060598","display_name":"Ugo De Giorgi","orcid":"https://orcid.org/0000-0001-7520-2908","observed_orcids":["https://orcid.org/0000-0001-7520-2908"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ugo De Giorgi","raw_affiliation_strings":["Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","institution_ids":["https://openalex.org/I4210097834"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.055,"has_fulltext":false,"cited_by_count":69,"citation_normalized_percentile":{"value":0.83493708,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"20","issue":"6A","first_page":"697","last_page":"701"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11686","display_name":"Dendrimers and Hyperbranched Polymers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2507","display_name":"Polymers and Plastics"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticancer-drug-delivery","display_name":"anticancer drug delivery","score":0.8420000076293945},{"id":"https://openalex.org/keywords/nanoparticles","display_name":"nanoparticles","score":0.9399999976158142},{"id":"https://openalex.org/keywords/drug-nanocarriers","display_name":"drug nanocarriers","score":0.9350000023841858},{"id":"https://openalex.org/keywords/enhanced-permeability-and-retention-effect","display_name":"enhanced permeability and retention effect","score":0.8960000276565552},{"id":"https://openalex.org/keywords/active-targeting","display_name":"active targeting","score":0.8399999737739563},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.968999981880188},{"id":"https://openalex.org/keywords/tumor-accumulation","display_name":"tumor accumulation","score":0.6200000047683716},{"id":"https://openalex.org/keywords/circulation-time","display_name":"circulation time","score":0.6159999966621399},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.6259999871253967},{"id":"https://openalex.org/keywords/nanomedicine","display_name":"nanomedicine","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C18150654","wikidata":"https://www.wikidata.org/wiki/Q17153796","display_name":"Nanocarriers","level":3,"score":0.8681908845901489},{"id":"https://openalex.org/C15083742","wikidata":"https://www.wikidata.org/wiki/Q261659","display_name":"Nanomedicine","level":3,"score":0.7885806560516357},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.7861654758453369},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6869611740112305},{"id":"https://openalex.org/C126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","level":3,"score":0.48467543721199036},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.48239031434059143},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.4642452001571655},{"id":"https://openalex.org/C2776165368","wikidata":"https://www.wikidata.org/wiki/Q11068","display_name":"Systemic circulation","level":2,"score":0.4398183226585388},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43214157223701477},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4293183982372284},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.3933388292789459},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26464539766311646},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.14749649167060852},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.05238935351371765}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D050997","descriptor_name":"Nanomedicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:17203748","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17203748","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"In vivo (Athens, Greece)","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unisalento.it:11587/542467","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11587/542467","pdf_url":null,"source":{"id":"https://openalex.org/S7407055257","display_name":"AIRUS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"mag:46975204","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17203748","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1503734031","https://openalex.org/W1546408466","https://openalex.org/W1973334995","https://openalex.org/W1992166069","https://openalex.org/W1993276667","https://openalex.org/W2000538955","https://openalex.org/W2001119928","https://openalex.org/W2009055622","https://openalex.org/W2009271486","https://openalex.org/W2027292955","https://openalex.org/W2037831947","https://openalex.org/W2057170991","https://openalex.org/W2069289981","https://openalex.org/W2070342688","https://openalex.org/W2071013022","https://openalex.org/W2072497728","https://openalex.org/W2073932571","https://openalex.org/W2079793032","https://openalex.org/W2081303479","https://openalex.org/W2090075420","https://openalex.org/W2091684294","https://openalex.org/W2093716333","https://openalex.org/W2093807603","https://openalex.org/W2095248480","https://openalex.org/W2106028056","https://openalex.org/W2108524724","https://openalex.org/W2111115146","https://openalex.org/W2112101570","https://openalex.org/W2117218524","https://openalex.org/W2142135649","https://openalex.org/W2145921425","https://openalex.org/W2149528981","https://openalex.org/W2152686312","https://openalex.org/W2153207740","https://openalex.org/W2154321074","https://openalex.org/W2163294691","https://openalex.org/W2164845223"],"related_works":["https://openalex.org/W2018364056","https://openalex.org/W2025326642","https://openalex.org/W4323036410","https://openalex.org/W4214861769","https://openalex.org/W2142135649","https://openalex.org/W4402728251","https://openalex.org/W3047043556","https://openalex.org/W4410052076","https://openalex.org/W2009911191","https://openalex.org/W2496859955"],"abstract_inverted_index":{"Nanotechnology":[0],"provides":[1],"a":[2,31,52,82],"variety":[3],"of":[4,16,30,51],"nanoscale":[5,65],"tools":[6,99],"for":[7,106],"medicine.":[8],"Among":[9],"them":[10],"nanoparticles":[11],"are":[12],"revolutionizing":[13],"the":[14,23,27,40,43,48,104],"field":[15],"drug":[17,20,108],"delivery.":[18],"These":[19],"nanocarriers":[21],"have":[22],"potential":[24],"to":[25,38,46,70,78,92,103],"enhance":[26],"therapeutic":[28],"efficacy":[29],"drug,":[32,53],"since":[33],"they":[34],"can":[35,67],"be":[36,68],"engineered":[37],"modulate":[39],"release":[41],"and":[42,45,75,81],"stability":[44],"prolong":[47],"circulation":[49],"time":[50],"protecting":[54],"it":[55],"from":[56],"elimination":[57],"by":[58,86],"phagocytic":[59],"cells":[60,74],"or":[61,85],"premature":[62],"degradation.":[63],"Moreover,":[64],"carriers":[66],"tailored":[69],"accumulate":[71],"in":[72],"tumour":[73],"tissues,":[76],"due":[77],"enhanced":[79],"permeability":[80],"retention":[83],"effect":[84],"active":[87],"targeting":[88],"using":[89],"ligands":[90],"designed":[91],"recognize":[93],"tumour-associated":[94],"antigens.":[95],"Could":[96],"these":[97],"nanomedicine":[98],"mark":[100],"an":[101],"end":[102],"necessity":[105],"loco-regional":[107],"delivery?":[109]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}